Exploring the pharmacological action mechanism of chamomile essential oil on the treatment of breast cancer based on network pharmacology
Our research suggest that CEO inhibit proliferation of breast cancer cell lines through modulating those multi-pathways and multi-targets. The present study not only indicate the therapeutic potential of CEO for breast cancer, but also provide valuable insight into its underlying mechanism.
Authors
- Guzhalinuer Maitisha
- Guangzhong Liu
- Junhao Zhou (ORCID: https://orcid.org/0009-0004-5749-2381)
- Ablikim Abliz
- Yan Daniel Zhao (ORCID: https://orcid.org/0000-0003-3448-0527)
- Ling Li (ORCID: https://orcid.org/0000-0002-9245-7387)
- Li Peng (ORCID: https://orcid.org/0000-0002-1360-1070)
- Yi Zheng (ORCID: https://orcid.org/0009-0000-6717-0395)
- Youyun Zhao (ORCID: https://orcid.org/0000-0003-3770-7635)
- Shuxia Han
Institutions
- Hubei Provincial Hospital of Traditional Chinese Medicine (CN)
- Central Hospital of Wuhan (CN)
Publication Details
- Journal
- BMC Complementary Medicine and Therapies
- Published
- 2025-10-17
- DOI
- https://doi.org/10.1186/s12906-025-05126-z
- Primary Topic
- Angiogenesis and VEGF in Cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Natural Science Foundation of Hubei Province